Education
About Us
Working with TipRanks
Follow Us
Springworks Therapeutics (SWTX)
NASDAQ:SWTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 191.59M | $ 5.45M | $ 6.15M | $ 0.00 | $ 35.00M |
| Gross Profit | $ 179.04M | $ 5.03M | $ 4.25M | $ -490.00K | $ 34.65M |
| Operating Income | $ -278.13M | $ -343.01M | $ -280.67M | $ -173.47M | $ -46.32M |
| EBITDA | $ -278.13M | $ -341.35M | $ -280.67M | $ -172.98M | $ -45.98M |
| Net Income | $ -258.13M | $ -325.10M | $ -274.16M | $ -173.21M | $ -44.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 307.99M | $ 479.20M | $ 597.01M | $ 373.50M | $ 508.48M |
| Total Assets | $ 587.28M | $ 725.79M | $ 630.24M | $ 452.49M | $ 576.19M |
| Total Debt | $ 7.91M | $ 7.06M | $ 5.25M | $ 1.29M | $ 2.73M |
| Net Debt | $ -61.84M | $ -169.00M | $ -62.24M | $ -102.67M | $ -144.35M |
| Total Liabilities | $ 106.17M | $ 99.57M | $ 72.05M | $ 30.10M | $ 19.13M |
| Stockholders' Equity | $ 481.10M | $ 626.22M | $ -569.93M | $ 422.40M | $ 557.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -180.05M | $ -230.18M | $ -171.76M | $ -129.89M | $ -32.83M |
| Operating Cash Flow | $ -175.60M | $ -222.79M | $ -161.56M | $ -127.88M | $ -32.19M |
| Investing Cash Flow | $ 64.55M | $ 34.75M | $ -215.60M | $ 83.59M | $ -418.83M |
| Financing Cash Flow | $ 4.76M | $ 296.64M | $ 340.70M | $ 1.16M | $ 270.49M |